In this biography
Quick facts
- Born
- 19 July 1921
- Died
- 30 May 2011
- Birthplace
- New York City, United States
- Country
- United States
- Nationality
- Not independently established
- Known for
- Radioimmunoassay developed with Solomon Berson
- Birth
- 19 July 1921, New York
- Doctorate
- Illinois, January 1945
- Bronx VA
- Part-time consultant from December 1947
- Death
- 30 May 2011, New York
Why this life matters
Her career connects physical measurement, a long clinical-research partnership and the distinction between what an assay detects and the biological question it can answer.
Timeline
Key moments
Birth
Born in New York City.
Hunter and Illinois
Graduated from Hunter and began graduate physics study.
Doctorate
Completed nuclear-physics research at Illinois.
Hospital consultancy
Joined the Bronx VA part-time in December.
Research partnership
Worked full-time at the VA and began collaboration with Berson.
Human plasma assay
Her lecture dates the first human-plasma measurement to this period.
Detailed paper
Published the endogenous-insulin study with Berson.
Nobel Prize
Received half of the Medicine Prize.
Death
Died on 30 May.
New York education led towards nuclear physics
Yalow was born in New York on 19 July 1921. Her account describes library visits, an interest in mathematics and encouragement from science teachers before she chose physics at Hunter College. She graduated in January 1941 and received a teaching assistantship at Illinois. There she combined heavy teaching and study while facing expectations that women did not belong in experimental physics. She completed a doctorate in nuclear physics in January 1945 with Maurice Goldhaber. The training gave her experience designing and using instruments to measure radioactive substances.
Teaching and a hospital consultancy overlapped
After industrial work she taught physics at Hunter and sought experience in medical applications of radioisotopes. Edith Quimby and other physicists helped introduce her to the Bronx Veterans Administration Hospital, where she became a part-time consultant in December 1947. She kept teaching while helping establish its radioisotope service. That hospital appointment should not be dated as the beginning of her partnership with Berson. Her autobiography places the move to full-time VA work in January 1950, their meeting that spring and his arrival in the service in July.
Sources for this section: [1]
An unexpected binding result changed the question
Yalow and Berson initially used radioisotopic methods for problems including blood volume, thyroid function and insulin metabolism. They observed that labelled insulin disappeared more slowly from the circulation of people previously treated with insulin. Their investigation implicated binding antibodies. What might have appeared to be an obstacle in one measurement became the basis for another: competition involving labelled and unlabelled material could help determine an unknown amount. Her Nobel lecture emphasises the several years of investigation between this observation and a practical plasma-insulin assay.
Standards turned a signal into an inference
The 1960 Journal of Clinical Investigation paper, coauthored with Berson, explains an assay of endogenous plasma insulin. Its principles compare the binding effect of an unknown with known insulin standards. The measured bound-to-free ratio is not itself a concentration or the fraction of all material that is bound. The inference depends on the reaction system and the comparison. Her later lecture also distinguishes immunologic behaviour from biological activity. This is the important scientific achievement: a sensitive measurement became useful through a defined relationship between a signal, standards and the question being asked.
The partnership lasted beyond its most famous method
The collaboration continued for twenty-two years until Berson’s death in April 1972. Yalow’s account describes reciprocal training: her physical-measurement background and his clinical and physiological expertise strengthened the work. Radioimmunoassay expanded into many research applications, but the uses of a method should be distinguished from proof that every particular assay is valid. Different substances, antibodies and samples require their own evidence. The linked learning guide uses fictional standards to illustrate that distinction; it does not reproduce a diagnostic test, a treatment decision or the operating procedures of the historical laboratory.
Recognition joined physics and biomedical research
Yalow received half of the 1977 Nobel Prize in Physiology or Medicine; Guillemin and Schally shared the other half for separate work. She was the second woman to receive the medicine prize. The VA’s historical account records her continued hospital career and retirement in 1991. She died on 30 May 2011. Her biography shows how a physicist’s approach to measurement could transform biomedical questions, while her account of education also documents the work and barriers behind a career often compressed into the name of a technique.
Quick answers
Frequently asked questions about Rosalyn S. Yalow
- Did Berson join Yalow in 1947?
- Her own account dates her hospital consultancy to 1947 and their research partnership to 1950.
- Does an assay’s binding signal measure biological activity directly?
- Not necessarily. The method’s defined immunologic comparison and the biological question must be kept distinct.
Keep exploring
Lives connected to this story
- Roger Y. Tsien
Compare another molecular-measurement programme in which calibration changes the interpretation.
- Paul Greengard
Explore another route from physical training into biochemical neuroscience.
- Eric R. Kandel
Compare the measurement of a biological signal with claims about a broader function.
Sources and further reading
Explore the evidence
These references support the biography and offer further reading. Official records, first-person accounts and independent reporting provide different perspectives; image records document attribution and licensing.
- 1. Nobel Foundation; Rosalyn YalowRosalyn Yalow: autobiographical account
Selectedearlyeducation/Illinois1945 and later1947/1950/Berson1959–1972 chronology read; not full memoir or every subsequent assay application.
- 2. Nobel FoundationRosalyn Yalow: prize facts
- 3. Rosalyn S. Yalow; Nobel FoundationRadioimmunoassay: A Probe for Fine Structure of Biologic Systems, 8 December1977
Actual22page lecture; PDF1 printed447 and PDF4–5 printed450–451 selectedtext read for Berson collaboration, competition, known standards, immunologic matching and distinction from isotope dilution. Not full paper replication or current diagnostic recommendation.
- 4. Rosalyn S. Yalow and Solomon A. Berson; Journal of Clinical InvestigationImmunoassay of endogenous plasma insulin in man, JCI39,1157–1175,1960
Actual20page publisherPDF including cover; selected PDF2 printed1157 introduction and PDF4 printed1159 Principles of immunoassay paragraphs read for specificity, comparative standards and B/F definition. Wholepaper/method replication not claimed; technical preparations not reproduced.
- 5. Parker Beverly; U.S. Department of Veterans AffairsDr. Rosalyn Yalow: Groundbreaking VA Medical Researcher and Nobel Prize Laureate,29June2022
Actual historical article read. Its bothparentsimmigrant statement contradicts Yalow’s own account of NewYork-bornfather; not adopted.1947hospitalentry separated from1950Bersonpartnership per autobiographicalsource. Page Gettyphotograph not treated as federalwork/reusable.
